Inotiv specializes in providing nonclinical and analytical drug discovery and development services. It's designed for pharmaceutical and biotech companies, government agencies, academia, and other life science organizations seeking comprehensive support for their research and development projects.

Key Offerings:

Nonclinical Services: Inotiv offers a wide array of services from early discovery through clinical development, helping organizations advance their drug candidates efficiently.
Research Models and Services: A broad range of research models is available, supporting various therapeutic areas and research needs. This includes specialized models for hypertension and other conditions.
Digital Pathology: The platform supports drug discovery projects with whole slide imaging and AI-driven quantitative image analysis, providing high precision and efficiency.
Monoclonal Antibody Production: Inotiv caters to both small and large-scale production needs, ensuring quality and flexibility for antibody projects.
Specialized Assays: Mass spectrometry assays are available for antibody drug conjugates (ADCs), quantifying target proteins in diverse sample types without needing antibodies.

Inotiv stands out for its comprehensive approach, integrating diverse services under one roof. This integration aids in streamlining the drug development process, reducing risk, and enhancing decision-making with reliable data. Whether you're looking to maximize animal welfare with enrichment solutions or need guidance on translational models, Inotiv provides tailored solutions to meet specific research and development needs.

Inotiv

Inotiv offers nonclinical drug discovery and development services, providing research models and related services for life sciences organizations.

United States

Visit Inotiv

Key Offerings:

Nonclinical Services: Inotiv offers a wide array of services from early discovery through clinical development, helping organizations advance their drug candidates efficiently.
Research Models and Services: A broad range of research models is available, supporting various therapeutic areas and research needs. This includes specialized models for hypertension and other conditions.
Digital Pathology: The platform supports drug discovery projects with whole slide imaging and AI-driven quantitative image analysis, providing high precision and efficiency.
Monoclonal Antibody Production: Inotiv caters to both small and large-scale production needs, ensuring quality and flexibility for antibody projects.
Specialized Assays: Mass spectrometry assays are available for antibody drug conjugates (ADCs), quantifying target proteins in diverse sample types without needing antibodies.